Bayer reports phase I results for prostate cancer therapy
Go back to Bayer reports phase I results for prostate cancer therapy| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) | Delayed: 11.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.25 | 52 Week High | $135.54 | |||
| Open | $11.25 | 52 Week Low | $94.36 | |||
| Day High | $11.25 | P/E | N/A | |||
| Day Low | $11.25 | EPS | $0.00 | |||
| Volume | 2,912 | |||||
| Bayer AG (AMEX: BAYZF) | Delayed: 44.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.07 | 52 Week High | $135.00 | |||
| Open | $44.07 | 52 Week Low | $94.95 | |||
| Day High | $44.07 | P/E | N/A | |||
| Day Low | $44.07 | EPS | $0.00 | |||
| Volume | 522 | |||||
